Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03737994
Brief Title: Biomarker/ALK Inhibitor Combinations in Treating Patients With Stage IV ALK Positive Non-squamous Non-small Cell Lung Cancer (The NCI-NRG ALK Protocol)

First Submitted : November 9, 2018
First Submitted that Met QC Criteria : November 9, 2018
First Posted : November 12, 2018 (Estimate)

Last Update Submitted that Met QC Criteria : September 19, 2019
Last Update Posted : September 20, 2019 (Estimate)